Skip to main content
SBFM logo
SBFM
(NASDAQ)
Sunshine Biopharma, Inc.
$1.71-- (--)
Loading... - Market loading

Sunshine Biopharma (SBFM) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Sunshine Biopharma, Inc.
SBFMNasdaq Stock MarketHealthcareDrug Manufacturers - Specialty & Generic

About Sunshine Biopharma

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone954 330 0684
Address
333 Las Olas Way, CU4 Suite 433 Fort Lauderdale, Florida 33301 United States

Corporate Identifiers

CIK0001402328
CUSIP867781809
ISINUS8677818093
EIN20-5566275
SIC2834

Leadership Team & Key Executives

Dr. Steve N. Slilaty Ph.D.
Chairman, President and Chief Executive Officer
Camille Sebaaly
Chief Financial Officer, Secretary and Director
Michel Roy
Chief Commercial Officer
Malek Chamoun
Chief Development Officer
Robert G. Ferreira
President of Sunshine Bio Investments Inc